PKCα-knockout APCMin/+ mice model display an elevated risk of intestinal tumors,13 suggesting that PKCα suppresses colon cancer development, whereas multiple studies revealed that PKCα confers drug resistance to human CRC cells.26 The gene discussed is PRKCA; the disease is colonic neoplasm.